TY - JOUR
T1 - Binding of the protein kinase PKR to RNAs with secondary structure defects
T2 - Role of the tandem A - G mismatch and noncontigous helixes
AU - Bevilacqua, Philip C.
AU - George, Cyril X.
AU - Samuel, Charles E.
AU - Cech, Thomas R.
PY - 1998/5/5
Y1 - 1998/5/5
N2 - The human interferon-induced double-stranded RNA (dsRNA)-activated protein kinase (PKR) is an antiviral agent that is activated by long stretches of dsRNA. PKR can also be activated or repressed by a series of cellular and viral RNAs containing non-Watson-Crick motifs. PKR has a dsRNA- binding domain (dsRBD) that contains two tandem copies of the dsRNA-binding motif (dsRBM). In vitro selection experiments were carried out to search for RNAs capable of binding to a truncated version of PKR containing the dsRBD. RNA ligands were selected by binding to His6-tagged proteins and chromatography on nickel(II) nitrilotriacetic acid agarose. A series of RNAs was selected that bind either similar to or tighter than a model dsRNA stem loop. Examination of these RNAs by a variety of methods, including sequence comparison, free-energy minimization, structure mapping, boundary experiments, site-directed mutagenesis, and footprinting, revealed protein- binding sites composed of noncontiguous helices. In addition, selected RNAs contained tandem A-G mismatches ((3'GA5')/(5'AG3')) yet bound to the truncated protein with affinities similar to duplexes containing only Watson- Crick base pairs. The NMR structure of the tandem A-G mismatch in an RNA helix (rGGCAGGCC)2 reveals a global A-form helix with minor perturbations at the mismatch [Wu, M., SantaLucia, J., Jr., and Turner, D. H. (1997) Biochemistry 36, 4449-4460]. This supports the notion that dsRBM-containing proteins can bind to RNAs with secondary structure defects as long as the RNA has an overall A-form geometry. In addition, selected RNAs are able to activate or repress wild-type PKR autophosphorylation as well as its phosphorylation of protein synthesis initiation factor eIF-2, suggesting full-length PKR can bind to and be regulated by RNAs containing a tandem A-G mismatch.
AB - The human interferon-induced double-stranded RNA (dsRNA)-activated protein kinase (PKR) is an antiviral agent that is activated by long stretches of dsRNA. PKR can also be activated or repressed by a series of cellular and viral RNAs containing non-Watson-Crick motifs. PKR has a dsRNA- binding domain (dsRBD) that contains two tandem copies of the dsRNA-binding motif (dsRBM). In vitro selection experiments were carried out to search for RNAs capable of binding to a truncated version of PKR containing the dsRBD. RNA ligands were selected by binding to His6-tagged proteins and chromatography on nickel(II) nitrilotriacetic acid agarose. A series of RNAs was selected that bind either similar to or tighter than a model dsRNA stem loop. Examination of these RNAs by a variety of methods, including sequence comparison, free-energy minimization, structure mapping, boundary experiments, site-directed mutagenesis, and footprinting, revealed protein- binding sites composed of noncontiguous helices. In addition, selected RNAs contained tandem A-G mismatches ((3'GA5')/(5'AG3')) yet bound to the truncated protein with affinities similar to duplexes containing only Watson- Crick base pairs. The NMR structure of the tandem A-G mismatch in an RNA helix (rGGCAGGCC)2 reveals a global A-form helix with minor perturbations at the mismatch [Wu, M., SantaLucia, J., Jr., and Turner, D. H. (1997) Biochemistry 36, 4449-4460]. This supports the notion that dsRBM-containing proteins can bind to RNAs with secondary structure defects as long as the RNA has an overall A-form geometry. In addition, selected RNAs are able to activate or repress wild-type PKR autophosphorylation as well as its phosphorylation of protein synthesis initiation factor eIF-2, suggesting full-length PKR can bind to and be regulated by RNAs containing a tandem A-G mismatch.
UR - http://www.scopus.com/inward/record.url?scp=0032485912&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032485912&partnerID=8YFLogxK
U2 - 10.1021/bi980113j
DO - 10.1021/bi980113j
M3 - Article
C2 - 9572845
AN - SCOPUS:0032485912
SN - 0006-2960
VL - 37
SP - 6303
EP - 6316
JO - Biochemistry
JF - Biochemistry
IS - 18
ER -